For those of you still interested, found this from a remap-cap twitter link. Jama Network. - Released 11th April 2023
Link: Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA | JAMA Network
Summary:
" In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes."
In terms of DMX-200 - needs someone smarter than me to delve into the details but looks like outcomes were available for only 6 critically ill patients randomized to the combined ARB and DMX-200 intervention prior to trial halt.
Wasn't the main game for sure, but anything good, could only help the share price from here!
- Forums
- ASX - By Stock
- Ann: REMAP-CAP COVID-19 Study Analysis Update
For those of you still interested, found this from a remap-cap...
-
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
|
|||||
Last
49.0¢ |
Change
0.040(8.89%) |
Mkt cap ! $269.6M |
Open | High | Low | Value | Volume |
46.0¢ | 50.5¢ | 46.0¢ | $2.255M | 4.621M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 49.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
49.5¢ | 21052 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.490 |
3 | 55686 | 0.485 |
5 | 45161 | 0.480 |
1 | 16686 | 0.475 |
3 | 118893 | 0.470 |
Price($) | Vol. | No. |
---|---|---|
0.495 | 21052 | 1 |
0.500 | 147789 | 5 |
0.505 | 119529 | 3 |
0.510 | 145686 | 4 |
0.515 | 170650 | 5 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |